Get started
Author

Fernando Leal da Costa

Observed names: Costa, Fernando Leal da, F. Leal-Da-costa, F. Leal‐da‐Costa, FERNANDO LEAL-DA-COSTA, Fernando Leal Da Costa, Fernando Leal-da-Costa
Observed institutions: Universidade do Porto, University of Alabama at Birmingham, Instituto Português de Oncologia Francisco Gentil, Escola Nacional de Saúde Pública Sergio Arouca, O'Neal Comprehensive Cancer Center, Centro de Investigação Farmacológica e Inovação Medicamentosa, Universidade Nova de Lisboa
OpenAlex ID: A5104013904
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
2017 · Michele Cavo, Evangelos Terpos, et al. · The Lancet Oncology · 549
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
2011 · Antonio Palumbo, Sara Bringhen, et al. · Blood · 354
PDF
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
2021 · Philippe Moreau, Shaji K Kumar, et al. · The Lancet Oncology · 280
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
2021 · Laura Rosiñol, Meral Beksac, et al. · British Journal of Haematology · 179
Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision
2020 · Rogério Sá Gaspar, Beatriz Silva-Lima, et al. · Frontiers in Medicine · 44
PDF
Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective
2011 · Heinz Ludwig, Meral Beksac, et al. · The Oncologist · 33
Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment
2010 · María-Victoria Mateos, Lucía López-Corral, et al. · Blood · 30
Large-Volume Leukaphereses May Be More Efficient Than Standard-Volume Leukaphereses for Collection of Peripheral Blood Progenitor Cells
1997 · JOSÉ LUIS PASSOS-COELHO, MARIA ALEXANDRA MACHADO, et al. · Journal of Hematotherapy · 23
Congenital amegakaryocytic thrombocytopenia—Report of a new c‐mpl gene missense mutation
2006 · J.L. Passos‐Coelho, M. Sebastião, et al. · American Journal of Hematology · 18
PDF
Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment
2011 · María-Victoria Mateos, Lucía López-Corral, et al. · Blood · 12
Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of Hematologists
2022 · Catarina Geraldes, Manuel Neves, et al. · Frontiers in Oncology · 11
PDF
A Randomized Study of Interferon α-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma
2013 · André Bosly, Andrew Grigg, et al. · The Oncologist · 6
PDF
A case of native valve infective endocarditis in an immunocompromised patient
2011 · Maria Salomé Carvalho, Marisa Trabulo, et al. · Revista Portuguesa de Cardiologia (English Edition) · 4
PDF
Um caso de endocardite infecciosa de válvula nativa em doente imunocomprometido
2011 · Maria Salomé Carvalho, Marisa Trabulo, et al. · Revista Portuguesa de Cardiologia · 4
[Biosimilars in oncology].
2009 · Sérgio Barroso, Jorge Coutinho, et al. · PubMed · 2
PDF
Stem cell transplantation as consolidation in peripheral T-cell lymphomas
2020 · Instituto Português Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal, Manuel Abecasis, et al. · Cellular Therapy and Transplantation · 1
PDF
Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?
2011 · Sergio Matarraz, Bruno Paiva, et al. · Blood · 1
Immune reconstitution and infectious complications following CAR-T cell therapy
2025 · Pedro Rodrigues Santos, Daniela Maia, et al. · Blood
PDF
Medicines Evaluation: The “Simplified” Complexity
2023 · Fernando Leal da Costa · Portuguese Journal of Public Health
How Allogeneic Hematopoietic Stem Cell Transplantation has Evolved Over Time: 30-Years’ Experience at a Single Institution
2020 · Manuel Abecasis, Nuno Miranda, et al. · Acta Médica Portuguesa
PDF
Low-Dose Dexamethasone Does Not Abrogate the Immunomodulatory Effects of Lenalidomide and Both Reactivate the Impaired Immune System of High-Risk Smoldering Multiple Myeloma Patients
2015 · Bruno Paiva, Maria-Victoria Mateos, et al. · Blood
Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,
2011 · Bruno Paiva, Maria Victoria Mateos, et al. · Blood
[High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
2011 · Margarida Brito, Pedro Sanchez, et al. · PubMed
PDF
Avaliação de desempenho dos hospitais públicos (Internamento) em Portugal Continental: 2008 : resultados : versão provisória
2010 · Carlos Costa, Fernando Leal da Costa, et al.
Clinical outcome of germ cell cancer patients (pts) treated with high-dose chemotherapy with stem cell support (HDC) –a single center experience
2004 · E. G. Dos Santos, F. Leal-Da-costa, et al. · Journal of Clinical Oncology
Works count: 27
Citation count: 1,551
H-index: 11
I10-index: 11
Year
Topic
Type